TY - JOUR
T1 - Machine learning consensus clustering approach for hospitalized patients with dysmagnesemia
AU - Thongprayoon, Charat
AU - Sy-Go, Janina Paula T.
AU - Nissaisorakarn, Voravech
AU - Dumancas, Carissa Y.
AU - Keddis, Mira T.
AU - Kattah, Andrea G.
AU - Pattharanitima, Pattharawin
AU - Vallabhajosyula, Saraschandra
AU - Mao, Michael A.
AU - Qureshi, Fawad
AU - Garovic, Vesna D.
AU - Dillon, John J.
AU - Erickson, Stephen B.
AU - Cheungpasitporn, Wisit
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/11
Y1 - 2021/11
N2 - Background: The objectives of this study were to classify patients with serum magnesium derangement on hospital admission into clusters using unsupervised machine learning approach and to evaluate the mortality risks among these distinct clusters. Methods: Consensus cluster analysis was performed based on demographic information, principal diagnoses, comorbidities, and laboratory data in hypomagnesemia (serum magnesium ≤ 1.6 mg/dL) and hypermagnesemia cohorts (serum magnesium ≥ 2.4 mg/dL). Each cluster’s key features were determined using the standardized mean difference. The associations of the clusters with hospital mortality and one-year mortality were assessed. Results: In hypomagnesemia cohort (n = 13,320), consensus cluster analysis identified three clusters. Cluster 1 patients had the highest comorbidity burden and lowest serum magnesium. Cluster 2 patients had the youngest age, lowest comorbidity burden, and highest kidney function. Cluster 3 patients had the oldest age and lowest kidney function. Cluster 1 and cluster 3 were associated with higher hospital and one-year mortality compared to cluster 2. In hypermagnesemia cohort (n = 4671), the analysis identified two clusters. Compared to cluster 1, the key features of cluster 2 included older age, higher comorbidity burden, more hospital admissions primarily due to kidney disease, more acute kidney injury, and lower kidney function. Compared to cluster 1, cluster 2 was associated with higher hospital mortality and one-year mortality. Conclusion: Our cluster analysis identified clinically distinct phenotypes with differing mortality risks in hospitalized patients with dysmagnesemia. Future studies are required to assess the application of this ML consensus clustering approach to care for hospitalized patients with dysmagnesemia.
AB - Background: The objectives of this study were to classify patients with serum magnesium derangement on hospital admission into clusters using unsupervised machine learning approach and to evaluate the mortality risks among these distinct clusters. Methods: Consensus cluster analysis was performed based on demographic information, principal diagnoses, comorbidities, and laboratory data in hypomagnesemia (serum magnesium ≤ 1.6 mg/dL) and hypermagnesemia cohorts (serum magnesium ≥ 2.4 mg/dL). Each cluster’s key features were determined using the standardized mean difference. The associations of the clusters with hospital mortality and one-year mortality were assessed. Results: In hypomagnesemia cohort (n = 13,320), consensus cluster analysis identified three clusters. Cluster 1 patients had the highest comorbidity burden and lowest serum magnesium. Cluster 2 patients had the youngest age, lowest comorbidity burden, and highest kidney function. Cluster 3 patients had the oldest age and lowest kidney function. Cluster 1 and cluster 3 were associated with higher hospital and one-year mortality compared to cluster 2. In hypermagnesemia cohort (n = 4671), the analysis identified two clusters. Compared to cluster 1, the key features of cluster 2 included older age, higher comorbidity burden, more hospital admissions primarily due to kidney disease, more acute kidney injury, and lower kidney function. Compared to cluster 1, cluster 2 was associated with higher hospital mortality and one-year mortality. Conclusion: Our cluster analysis identified clinically distinct phenotypes with differing mortality risks in hospitalized patients with dysmagnesemia. Future studies are required to assess the application of this ML consensus clustering approach to care for hospitalized patients with dysmagnesemia.
KW - Artificial intelligence
KW - Clustering
KW - Consensus clustering
KW - Dysmagnesemia
KW - Electrolytes
KW - Hypermagnesemia
KW - Hypomagnesemia
KW - Individualized medicine
KW - Machine learning
KW - Magnesium
KW - Mortality
KW - Nephrology
KW - Personalized medicine
KW - Precision medicine
UR - http://www.scopus.com/inward/record.url?scp=85119614134&partnerID=8YFLogxK
U2 - 10.3390/diagnostics11112119
DO - 10.3390/diagnostics11112119
M3 - Article
AN - SCOPUS:85119614134
SN - 2075-4418
VL - 11
JO - Diagnostics
JF - Diagnostics
IS - 11
M1 - 2119
ER -